TME PHARMA
Live / Registered — Registered (as of 25 Jun 2024)
What this means for you
Registered since 25 Jun 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79360076
- Registration number
- 7423863
- Mark type
- Design + words
- Filed
- 03 Nov 2022
- Published for opposition
- 09 Apr 2024
- Registered
- 25 Jun 2024
- Attorney of record
- Ursula B. Day
Goods and services
- Class 001 — Chemicals: Chemicals for use in industry and science, in particular compounds of nucleic acids and derivatives thereof and l-nucleotides and proteins and peptides and derivatives thereof, all for use in the production and development of pharmaceuticals, veterinary and biotechnological products;
- Class 005 — Pharmaceuticals: Medicines, medical preparations and medicines for animals, namely, for treating cancer and ophthalmological indications, diagnostic agents for pharmaceutical use; pharmaceuticals and natural remedies, namely, for treating cancer and ophthalmological indications; pharmaceutical compositions, namely, for treating cancer and ophthalmological indications; pharmaceutical preparations, namely, for treating cancer and ophthalmological indications;
- Class 042 — Scientific and technological services: Science and technology services, namely, scientific analysis in the field of biotechnology, therapeutics and research and planning services relating to development of pharmaceuticals; medical and pharmacological research services; pharmaceutical research; computer software design; design of databases, design of online databases; computer programming, namely, updating, design and rental of computer software for managing medical patient data, medical teaching and interactive medical simulations; providing online, non-downloadable computer programs and data networks for managing medical patient data, medical teaching and interactive medical simulations; scientific and technological services, namely, scientific analysis in the field of biotechnology, therapeutics and research and design relating thereto in the field of genetic engineering; scientific research for medical purposes and for biochemical use, scientific contract research; research and development of processes, syntheses and devices for the medical sector and research in the fields of chemistry, biology, biophysics, medicine, biochemistry, genetics, genetic engineering, bacteriology; scientific experiments and analyses; surveying; chemistry services, namely, laboratory research in the field of chemistry, biotechnology, medicine; chemical laboratories; medical laboratory services
- Class 044 — Medical, beauty and agricultural services: Medical services in the field of medicine; medical and clinical examinations; pharmaceutical advice;
Owner
- TME Pharma AG, DE
- TME Pharma AG, DE
- TME Pharma AG, DE
Prosecution history
- 21 Mar 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 05 Jan 2025 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 12 Dec 2024 — FINAL DISPOSITION NOTICE SENT TO IB
- 11 Dec 2024 — FINAL DISPOSITION PROCESSED
- 25 Sept 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 25 Jun 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Jun 2024 — REGISTERED-PRINCIPAL REGISTER
- 10 Jun 2024 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 15 Apr 2024 — NOTIFICATION PROCESSED BY IB
- 09 Apr 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Apr 2024 — PUBLISHED FOR OPPOSITION
- 27 Mar 2024 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 27 Mar 2024 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 20 Mar 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Feb 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER